argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
26 feb 2026 - 06:30
Statutory name
argenx SE
Title
argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
Related downloads
Date last update: 05 April 2026